Neumora Therapeutics, Inc.

Neumora Therapeutics is a drug development company working on treatments for brain and neurological conditions. The company is testing several experimental medicines, including navacaprant for depression, which is in late-stage clinical trials, and other drugs for dementia, schizophrenia, Parkinson's disease, and other neuropsychiatric disorders. The company is still in the research and testing phase and has not yet brought any medicines to market.